Stock Alert: Zogenix Tumbles 15%; Proposes $200 Mln Note Offering

(RTTNews) - Shares of Zogenix Inc. (ZGNX) are falling more than 15 percent or $3.40 in Wednesday's morning trade at $19.18.

Tuesday, Zogenix said it intends to offer $200 million aggregate principal amount of convertible senior notes due 2027 in a private offering to qualified institutional buyers.

The biopharmaceutical company intends to use the net proceeds from the offering to fund development and commercialization of Fintepla in Dravet syndrome, Lennox-Gastaut syndrome, and other potential indications; to fund the development of MT1621 in TK2 deficiency and other general corporate purposes.

Zogenix has traded in a range of $16.65 to $57.22 in the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More